European Commission President Ursula von der Leyen announced on Wednesday that the European Union is negotiating with Pfizer-BioNTech to order 1.8 billion doses of vaccine against the variants
BioNTech and Pfizer laboratories will increase the deliveries of their anti-Covid vaccine to the EU by 50 million doses in the second quarter, to reach 250 million doses over the period, she added.
Read also: Faced with Europe, the vaccine revenge of Boris Johnson
The delivery of these additional doses, initially scheduled for the 4th quarter, will begin in April. This announcement comes as the American Johnson & Johnson, which is to deliver 55 million doses to the Twenty-Seven in the second quarter, announced Tuesday "
delay the deployment
" of its single-dose vaccine in Europe.
